Log In
BCIQ
Print this Print this
 

Dolcanatide (SP-333)

  Manage Alerts
Collapse Summary General Information
Company Synergy Pharmaceuticals Inc.
DescriptionSecond-generation guanylate cyclase C (GCC; GUCY2C) agonist
Molecular Target Guanylate cyclase C (GCC) (GUCY2C)
Mechanism of ActionGuanylate cyclase C agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$185.1M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/28/2013

$185.1M

0

0

Get a free BioCentury trial today